Quick Menu

Upcoming Journals

Asian Journal of Medicine and Health

Asian Journal of Medicine and Health, 2456-8414,Vol.: 6, Issue.: 3

Original-research-article

Antiretroviral Therapy may have Anxiogenic Effect on Subjects

 

C. O. Nku1, I. O. Ajiwhen1*, M. Odo2, S. A. Bisong1 and E. E. Osim1

1Department of Physiology, Faculty of Basic Medical Sciences, University of Calabar, Nigeria.

2Department of Anatomy, Faculty of Basic Medical Sciences, University of Calabar, Nigeria.

 

Article Information

Editor(s):

(1) Triveni Krishnan, Division of Virology, National Institute of Cholera and Enteric Diseases, Kolkata, India.

(2) Giuseppe Murdaca, Clinical Immunology Unit, Department of Internal Medicine, University of Genoa, Italy.

Reviewers:

(1) Maria Demetriou, Democritus University, Greece.

(2) Carlos M. Contreras, National Autonomous University of Mexico, Mexico.

(3) Aurea Regina Telles Pupulin, State University of Maringa, Brazil.

(4) Kelvin K. Juma, Kenyatta University, Kenya.

(5) Nélida Virginia Gómez, Buenos Aires University, Argentina.

Complete Peer review History: http://www.sciencedomain.org/review-history/20457

 

Abstracts

 

Aims: To observe the effects of the antiretroviral drugs, Lamivudine, Zidovudine, and Efavirenz individually and in combination on locomotor behavior and anxiety.

Methods: Fifty (50) mice were divided into five (5) groups of ten (10) mice each. Group one served as control and was given normal saline. The next three groups received oral solutions of Lamivudine, Zidovudine, and Efavirenz respectively at doses of 2 mg/kg, 4 mg/kg and 8 mg/kg at volumes not exceeding 10 ml/kg body weight (i.e. 0.1 ml/10 g). The fifth group received a combined oral solution of the three antiretroviral drugs.

Results: In the Open field test, the frequency of line crossing, rearing frequency, and centre square entry are significantly (P=0.05) lower in the antiretroviral treated groups compared to the control, with a significantly higher centre square entry in the combined treated group than in the individual treated groups. In the light/dark transition box, it was observed that the duration in the light chamber was significantly (p=0.05) lower in the lamivudine and Efavirenz treated groups compared to control. The duration in the Zidovudine and combined treatment groups, though lowered, was not significantly different. There was an increase in grooming duration in the Efavirenz and the combined treatment groups, and a significant decrease in transitions in all the treatment groups compared to control. In the elevated plus maze, the frequency of open arm entry is significantly lower in the Efavirenz treated group compared to control. It is also significantly higher in the combined treatment group compared to all three individual treatment groups. The open arm duration is significantly lower in the three individual treatment groups compared to control. It is significantly lower in the Efavirenz treated group compared to the lamivudine and Zidovudine treated groups. The frequency of head dip did not differ significantly in the lamivudine and Zidovudine treated groups compared to control. It is significantly lower in the Efavirenz treated group compared to control. However it is significantly higher in the combined treatment group compared to control.

Conclusion: Taken together, our findings indicate an anxiogenic effect of antiretroviral therapy. However our results do not show a conclusive evidence that combined antiretroviral therapy has a greater anxiogenic effect on the subjects than single antiretroviral therapy.

 

Keywords :

Lamivudine; Zidovudine; Efavirenz; anxiety; locomotor behavior.

 

Full Article - PDF    Page 1-11    Article Metrics

 

DOI : 10.9734/AJMAH/2017/30307

Review History    Comments

Search this site

Advanced Search

Announcement & News

Nature (Impact Factor: 41.6) confirmed high standard of SDI journal and its editors

We are happy to inform that Nature (Impact Factor: 41.6) confirmed high standard of SDI journal and ...

ISI Thomson Reuters selected British Journal of Pharmaceutical Research for Emerging Sources Citation Index

We are delighted to inform that ISI Thomson Reuters selected British Journal of Pharmaceutical Resea...

SCOPUS selected Annual Research & Review in Biology (ARRB)

We are delighted to inform that famous indexing organization SCOPUS (from Elsevier) selected  A...

Index Copernicus Evaluation Result Released

We are delighted to inform that Index Copernicus (a leading indexing organization from Pol...

Journal Repository (JR): Permanent Digital Archiving of SDI journals

SDI is happy to announce that all our journals are now permanently archived in Journal Repository (J...

SDI journal got 35th ranking in Publons

We are delighted to announce (as of 04/01/2016) that British Journal of Medicine and Medical Re...

Growth of SDI and world publication market

As of 2014, total 25,064 journals are competing in World market of journal publication. In 2011, tot...

Science (IF: 31) report confirmed the high standard of SDI journal

As per a recent report (Link) of Science journal (present Impact factor 31), one of our journal (Bri...

SDI introduced Post-publication peer review by its comment section

SDI journals encourage Post-publication peer review by its comment section   Policy details a...

SDI promotes transparent Advanced OPEN peer review

We have migrated to transparent and toughest ‘Advanced OPEN peer review’ system (...



SCIENCEDOMAIN Awards

  • No Awards listed.

Browser Compatibility : Mozila firefox, Google Crome and IE 7 & above. Creative Commons License Terms & Condition   |   Privacy Policy   |   Join Us   |   Help   |   Contact Us
© Copyright 2010-2018, SCIENCEDOMAIN international. All rights reserved.